[Rules and regulations threaten non-pharmacological studies in children]

Marjolein J C Schot1, Berna D L Broekhuizen, Jochen W L Cals

  • 1UMC Utrecht, Julius Centrum voor Gezondheidswetenschappen en Eerstelijns Geneeskunde, Utrecht.

Insights

Research into non-pharmacological interventions for children is lacking due to regulatory hurdles. Adapting current rules could facilitate essential child healthcare research.

Area of Science:

  • Pediatric healthcare research
  • Child health interventions
  • Regulatory science in pediatrics

Background:

  • Limited evidence exists for non-pharmacological interventions in pediatric populations.
  • Existing research predominantly focuses on adult populations.
  • There is a need to expand evidence-based interventions for children.

Purpose of the Study:

  • To address the gap in research on non-pharmacological interventions for children.
  • To examine current regulations governing research in children in the Netherlands.
  • To explore potential adaptations to regulations for low-risk pediatric research.

Main Methods:

  • Review of current Dutch regulations on child research.
  • Analysis of the impact of regulations on low-risk, minimal-burden interventions.
  • Discussion of regulatory adaptation possibilities based on research type.

Main Results:

  • Current regulations present significant challenges for conducting pediatric research.
  • Low-risk, minimal-burden interventions face disproportionate regulatory burdens.
  • Specific regulatory adjustments are feasible and necessary.

Conclusions:

  • Adapting regulations is crucial for advancing child healthcare research.
  • Facilitating research into non-pharmacological interventions can improve pediatric care.
  • A balanced regulatory approach is needed to encourage, not hinder, vital child health studies.

Related Concept Videos

Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...